Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022
– Early proof-of-concept data support durable clinical benefit including confirmed partial response and stable disease…
Smokers in New Zealand are Still Waiting for a Promised Reform
GA-ASI and Saab Perform Advanced AEW Flight Testing on Uncrewed MQ-9B
SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
HKTDC Chairman deepens Hong Kong-GCC business ties with visit to Qatar
Xunce Launches TokenRouters Building a Dedicated Token Exchange Hub and Enterprise AI Core Platform, Ushering in the Era of “Interchangeable” AI Resources